Schematic overview of the cellular and molecular mechanisms involved in the cancer progression, including the proposed cellular and molecular mechanisms in cancer cells trajectory. AT1: alveolar type 1 cells; AT2: alveolar type 2 cells; AAH: atypical adenomatous hyperplasia; AIS: adenocarcinoma in situ; MIA: minimally invasive adenocarcinoma; IA: invasive adenocarcinoma; EMT: epithelial-mesenchymal transition

Home

Download

Statistics

Help

Contact

Center for Computational Systems Medicine
leaf

Gene summary

leaf

Malignant transformation analysis

leaf

Malignant transformation related pathway analysis

leaf

Cell-cell communication analysis

leaf

Single-cell gene regulatory network inference analysis

leaf

Somatic mutation of malignant transformation related genes

leaf

Related drugs of malignant transformation related genes

Gene: STMP1

Gene summary for STMP1

check button Gene summary.

Gene informationSpeciesHuman
Gene symbol

STMP1

Gene ID

647087

Gene nameshort transmembrane mitochondrial protein 1
Gene AliasC7orf73
Cytomap7q33
Gene Typeprotein-coding
GO ID

GO:0001816

UniProtAcc

E0CX11


Top

Malignant transformation analysis

check button Identification of the aberrant gene expression in precancerous and cancerous lesions by comparing the gene expression of stem-like cells in diseased tissues with normal stem cells
check button Malignant transformation involving gene list.
Entrez IDSymbolReplicatesSpeciesOrganTissueAdj P-valueLog2FCMalignancy
647087STMP1S028HumanLiverHCC1.20e-521.95e+000.2503
647087STMP1S029HumanLiverHCC5.32e-442.26e+000.2581
647087STMP1Pat01-BHumanStomachGC2.94e-203.74e-010.5754
647087STMP1Pat02-BHumanStomachGC7.22e-365.15e-010.0368
647087STMP1Pat03-BHumanStomachGC3.28e-223.76e-010.3693
647087STMP1Pat04-BHumanStomachGC2.99e-325.87e-01-0.1483
647087STMP1Pat05-BHumanStomachGC9.70e-225.18e-01-0.0353
647087STMP1Pat06-BHumanStomachGC3.65e-395.67e-01-0.1961
647087STMP1Pat07-BHumanStomachGC9.58e-145.50e-010.0935
647087STMP1Pat08-BHumanStomachGC2.96e-135.19e-010.0182
647087STMP1Pat09-BHumanStomachGC8.00e-173.80e-01-0.0359
647087STMP1Pat10-BHumanStomachGC7.31e-083.53e-010.084
647087STMP1Pat11-BHumanStomachGC1.84e-194.71e-01-0.182
647087STMP1Pat12-BHumanStomachGC2.78e-173.23e-010.0325
647087STMP1Pat13-BHumanStomachGC1.03e-215.06e-010.0555
647087STMP1Pat15-BHumanStomachGC6.88e-203.83e-01-0.0778
647087STMP1Pat16-BHumanStomachGC3.73e-122.44e-010.1918
647087STMP1Pat17-BHumanStomachGC4.30e-092.85e-010.3109
647087STMP1Pat18-BHumanStomachGC1.67e-234.34e-01-0.0432
647087STMP1Pat19-BHumanStomachGC2.79e-113.04e-010.0826
Page: 1 2 3 4 5 6 7 

check button Transcriptomic changes along malignancy continuum.
TissueExpression DynamicsAbbreviation
BreastThe image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.IDC: Invasive ductal carcinoma
DCIS: Ductal carcinoma in situ
Precancer(BRCA1-mut): Precancerous lesion from BRCA1 mutation carriers
Colorectum (GSE201348)The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.FAP: Familial adenomatous polyposis
CRC: Colorectal cancer
Colorectum (HTA11)The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.AD: Adenomas
SER: Sessile serrated lesions
MSI-H: Microsatellite-high colorectal cancer
MSS: Microsatellite stable colorectal cancer
EndometriumThe image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.AEH: Atypical endometrial hyperplasia
EEC: Endometrioid Cancer
EsophagusThe image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.ESCC: Esophageal squamous cell carcinoma
HGIN: High-grade intraepithelial neoplasias
LGIN: Low-grade intraepithelial neoplasias
GCThe image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.CAG: Chronic atrophic gastritis
CAG with IM: Chronic atrophic gastritis with intestinal metaplasia
CSG: Chronic superficial gastritis
GC: Gastric cancer
SIM: Severe intestinal metaplasia
WIM: Wild intestinal metaplasia
LiverThe image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.HCC: Hepatocellular carcinoma
NAFLD: Non-alcoholic fatty liver disease
ThyroidThe image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.ATC: Anaplastic thyroid cancer
HT: Hashimoto's thyroiditis
PTC: Papillary thyroid cancer
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.

Top

Malignant transformation related pathway analysis

check buttonFind out the enriched GO biological processes and KEGG pathways involved in transition from healthy to precancer to cancer
check button Figure of enriched GO biological processes.
TissueDisease StageEnriched GO biological Processes
ColorectumADGO analysis - Figure of enriched GO biological processes: Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).
ColorectumSERGO analysis - Figure of enriched GO biological processes: Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).
ColorectumMSSGO analysis - Figure of enriched GO biological processes: Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).
ColorectumMSI-HGO analysis - Figure of enriched GO biological processes: Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).
ColorectumFAPGO analysis - Figure of enriched GO biological processes: Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).
Page: 1 2 3 4 5 6 7 8 9 

check button Enriched GO biological processes.
GO IDTissueDisease StageDescriptionGene RatioBg Ratiopvaluep.adjustCount
GO:00432549BreastPrecancerregulation of protein-containing complex assembly50/1080428/187231.63e-065.97e-0550
GO:00313349BreastPrecancerpositive regulation of protein-containing complex assembly33/1080237/187232.39e-068.21e-0533
GO:00018196BreastPrecancerpositive regulation of cytokine production52/1080467/187234.18e-061.29e-0452
GO:0032732BreastPrecancerpositive regulation of interleukin-1 production11/108073/187232.96e-032.55e-0211
GO:004325414BreastIDCregulation of protein-containing complex assembly61/1434428/187231.77e-067.31e-0561
GO:003133414BreastIDCpositive regulation of protein-containing complex assembly40/1434237/187231.77e-067.31e-0540
GO:000181911BreastIDCpositive regulation of cytokine production61/1434467/187232.81e-056.58e-0461
GO:004325424BreastDCISregulation of protein-containing complex assembly61/1390428/187236.32e-072.71e-0561
GO:003133423BreastDCISpositive regulation of protein-containing complex assembly40/1390237/187238.13e-073.36e-0540
GO:000181921BreastDCISpositive regulation of cytokine production63/1390467/187232.76e-069.42e-0563
GO:00327321BreastDCISpositive regulation of interleukin-1 production13/139073/187232.57e-032.30e-0213
GO:0043254ColorectumADregulation of protein-containing complex assembly148/3918428/187232.64e-113.18e-09148
GO:0031334ColorectumADpositive regulation of protein-containing complex assembly91/3918237/187234.78e-103.99e-0891
GO:00432542ColorectumMSSregulation of protein-containing complex assembly130/3467428/187231.38e-091.03e-07130
GO:00313342ColorectumMSSpositive regulation of protein-containing complex assembly82/3467237/187232.49e-091.75e-0782
GO:004325416EndometriumAEHregulation of protein-containing complex assembly83/2100428/187233.90e-071.63e-0583
GO:003133416EndometriumAEHpositive regulation of protein-containing complex assembly52/2100237/187231.43e-064.60e-0552
GO:00018198EndometriumAEHpositive regulation of cytokine production71/2100467/187234.76e-033.02e-0271
GO:004325417EndometriumEECregulation of protein-containing complex assembly83/2168428/187231.44e-064.64e-0583
GO:003133417EndometriumEECpositive regulation of protein-containing complex assembly52/2168237/187233.68e-069.90e-0552
Page: 1 2 3 

check button Enriched KEGG pathways.
Pathway IDTissueDisease StageDescriptionGene RatioBg Ratiopvaluep.adjustqvalueCount
Page: 1 

Top

Cell-cell communication analysis

check buttonIdentification of potential cell-cell interactions between two cell types and their ligand-receptor pairs for different disease states
LigandReceptorLRpairPathwayTissueDisease Stage
Page: 1 

Top

Single-cell gene regulatory network inference analysis

check buttonFind out the significant the regulons (TFs) and the target genes of each regulon across cell types for different disease states
TFCell TypeTissueDisease StageTarget GeneRSSRegulon Activity
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression.
Page: 1 

Top

Somatic mutation of malignant transformation related genes

check buttonAnnotation of somatic variants for genes involved in malignant transformation
Hugo SymbolVariant ClassVariant ClassificationdbSNP RSHGVScHGVSpHGVSp ShortSWISSPROTBIOTYPESIFTPolyPhenTumor Sample BarcodeTissueHistologySexAgeStageTherapy TypesDrugsOutcome
Page: 1 

Top

Related drugs of malignant transformation related genes

check buttonIdentification of chemicals and drugs interact with genes involved in malignant transfromation
(DGIdb 4.0)
Entrez IDSymbolCategoryInteraction TypesDrug Claim NameDrug NamePMIDs
Page: 1